Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants
PHASE2CompletedINTERVENTIONAL
Enrollment
69
Participants
Timeline
Start Date
April 30, 2013
Primary Completion Date
May 31, 2015
Study Completion Date
August 31, 2015
Conditions
Bronchopulmonary Dysplasia
Interventions
BIOLOGICAL
Pneumostem®
OTHER
Normal Saline
Trial Locations (2)
Unknown
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
All Listed Sponsors
lead
Medipost Co Ltd.
INDUSTRY
NCT01828957 - Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants | Biotech Hunter | Biotech Hunter